Seeger JD - Search Results

1

The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.

Enger C, Younus M, Petronis KR, Mo J, Gately R, Seeger JD. Enger C, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):705-15. doi: 10.1002/pds.3400. Epub 2013 Jan 24. Pharmacoepidemiol Drug Saf. 2013. PMID: 23349095

2

Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.

Eng PM, Seeger JD, Loughlin J, Clifford CR, Mentor S, Walker AM. Eng PM, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):297-305. doi: 10.1002/pds.1554. Pharmacoepidemiol Drug Saf. 2008. PMID: 18215000

3

Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study.

Funch D, Norman H, Wong J, Bennett R, Hillier J, Al-Sabbagh A, Seeger JD. Funch D, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2010 May;19(5):448-56. doi: 10.1002/pds.1918. Pharmacoepidemiol Drug Saf. 2010. PMID: 20333778

4

Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus.

Dore DD, Chaudhry S, Hoffman C, Seeger JD. Dore DD, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):209-13. doi: 10.1002/pds.2077. Epub 2010 Dec 23. Pharmacoepidemiol Drug Saf. 2011. PMID: 21254293

5

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.

Kesselheim AS, Donneyong M, Dal Pan GJ, Zhou EH, Avorn J, Schneeweiss S, Seeger JD. Kesselheim AS, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2017 Jun;26(6):712-721. doi: 10.1002/pds.4215. Epub 2017 Apr 27. Pharmacoepidemiol Drug Saf. 2017. PMID: 28449404

6

Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care.

Nunes AP, Loughlin AM, Qiao Q, Ezzy SM, Yochum L, Clifford CR, Gately RV, Dore DD, Seeger JD. Nunes AP, et al. Among authors: seeger jd. Diabetes Ther. 2017 Dec;8(6):1349-1364. doi: 10.1007/s13300-017-0314-z. Epub 2017 Oct 5. Diabetes Ther. 2017. PMID: 28983857 Free PMC article.

7

Effectiveness and tolerability of therapy with exenatide once weekly vs basal insulin among injectable-drug-naïve elderly or renal impaired patients with type 2 diabetes in the United States.

Loughlin AM, Qiao Q, Nunes AP, Öhman P, Ezzy S, Yochum L, Clifford CR, Gately R, Dore DD, Seeger JD. Loughlin AM, et al. Among authors: seeger jd. Diabetes Obes Metab. 2018 Apr;20(4):898-909. doi: 10.1111/dom.13175. Epub 2018 Jan 3. Diabetes Obes Metab. 2018. PMID: 29193561 Free PMC article.

8

Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey.

Amend KL, Younus M, Petronis KR, Mo J, Seeger JD, Gately R, Gu X, Enger C. Amend KL, et al. Among authors: seeger jd. Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):253-262. doi: 10.1002/pds.4373. Epub 2018 Feb 6. Pharmacoepidemiol Drug Saf. 2018. PMID: 29405516

9

Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States.

Loughlin AM, Qiao Q, Nunes AP, Ezzy SM, Yochum L, Clifford CR, Gately RV, Dore DD, Seeger JD. Loughlin AM, et al. Among authors: seeger jd. Diabetes Spectr. 2018 May;31(2):129-137. doi: 10.2337/ds16-0081. Diabetes Spectr. 2018. PMID: 29773932 Free PMC article.

10

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.

Hoffman V, Hallas J, Linder M, Margulis AV, Suehs BT, Arana A, Phiri K, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S, Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD; mirabegron PMR-PASS study group. Hoffman V, et al. Among authors: seeger jd. Drug Saf. 2021 Aug;44(8):899-915. doi: 10.1007/s40264-021-01095-7. Epub 2021 Jul 8. Drug Saf. 2021. PMID: 34236595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page